Pfizer to launch half of the vaccine as planned

By the end of the year, the US pharmaceutical company Pfizer will release half the doses of the coronavirus vaccine than planned. And the reason was problems with the supply of raw materials, as the official version says.

Fox News reports.

So initially, by the end of 2020, Pfizer and its German partner BioNTech planned to supply 100 million doses of the vaccine, and will instead launch just 50 million, due to problems with the supply of raw materials for the drug, which faced the company.

They clarify that the companies’ plans for the production of the vaccine for 2021 have not changed, they still expect to release more than one billion doses of the drug. A Pfizer spokesperson said the results of a clinical trial of the vaccine were available later than expected. But now all the problems are solved.

Recall that the first batch of BioNTech’s Pfizer COVID-19 vaccine has already arrived in Britain.

It was also reported that the delivery of the drug to different countries of the world has begun. Pfizer plans to store the first batches of vaccines in warehouses in Michigan and Wisconsin, as well as in Belgium and Germany.